Patents by Inventor Justin Chakma

Justin Chakma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclopropane carboxamide modulators of cystic fibrosis transmembrane conductance regulator
    Patent number: 10689370
    Abstract: The present invention relates to new cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator proteins, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: June 23, 2020
    Assignee: AUSPEX PHARMACEUTICALS, INC.
    Inventors: Chengzhi Zhang, Justin Chakma
  • Cyclopropane Carboxamide Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
    Publication number: 20190367492
    Abstract: The present invention relates to new cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator proteins, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: December 19, 2018
    Publication date: December 5, 2019
    Inventors: Chengzhi ZHANG, Justin CHAKMA
  • AZETIDINE MODULATORS OF THE SPHINGOSINE 1-PHOSPHATE RECEPTOR
    Publication number: 20190047951
    Abstract: Described are deuterium-substituted azetidine compounds of Formula (I), which are modulators of sphingosine 1-phosphate receptor. Also described are pharmaceutical compositions comprising the deuterium-substituted azetidine compounds, and methods of use thereof.
    Type: Application
    Filed: January 3, 2017
    Publication date: February 14, 2019
    Inventors: Chengzhi ZHANG, Justin CHAKMA
  • Cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator
    Patent number: 10167278
    Abstract: The present invention relates to new cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator proteins, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: December 27, 2015
    Date of Patent: January 1, 2019
    Assignee: Auspex Pharmaceuticals, Inc.
    Inventors: Chengzhi Zhang, Justin Chakma
  • CYCLOPROPANECARBOXAMIDE MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
    Publication number: 20180265501
    Abstract: The present invention relates to new cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator proteins, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: December 27, 2015
    Publication date: September 20, 2018
    Inventors: Chengzhi ZHANG, Justin CHAKMA
  • DEUTERIUM-SUBSTITUTED OXADIAZOLES
    Publication number: 20180016244
    Abstract: Described are deuterated modulators of S1P1 receptors, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: March 25, 2016
    Publication date: January 18, 2018
    Inventors: Chengzhi Zhang, Justin Chakma